CPRX
Catalyst Pharmaceuticals Inc
Price:
23.4
USD
Volume:
1,177,597
United States | Biotechnology
CPRX Net Margin
As of 2025-05-15, the Net Margin of Catalyst Pharmaceuticals Inc (CPRX) is 33.3%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
CPRX Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 33.3% |
| 2023-12-31 | 17.9% |
| 2022-12-31 | 38.8% |
| 2021-12-31 | 28.1% |
| 2020-12-31 | 63% |
| 2019-12-31 | 31.2% |
| 2018-12-31 | -6800% |
| 2017-12-31 | - |
| 2016-12-31 | - |
| 2015-12-31 | - |
CPRX Net Margin - Peers Comparison